|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00540215 |
|
Date of registration:
|
04/10/2007 |
|
Primary sponsor: |
|
|
Public title:
|
GLP-2 (Glucagonlike Peptide-2) and Blood Flow
|
|
Scientific title:
|
The Role of GLP-2 in Univercal Changes in Blood Flow in Humans |
|
Date of first enrolment:
|
October 2007 |
|
Target sample size:
|
15 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00540215 |
|
Study type:
|
Interventional |
|
Study design:
|
Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science
|
|
|
Countries of recruitment
|
|
Denmark
| | | | | | | |
|
Contacts
|
|
Name:
|
lasse bremholm, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Glostrup university hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age 20-60
- Healthy
- No medication
- Not pregnant
Exclusion Criteria:
- All of the persons not meeting the abowe mentioned criteria
Age minimum:
20 Years
Age maximum:
60 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Regional Blood Flow
|
|
Intervention(s)
|
|
Other: Glucagonlike peptide
|
|
Primary Outcome(s)
|
|
effect of glp-2
[Time Frame: during study]
|
|
Secondary Outcome(s)
|
|
potential new ideas for further studies
[Time Frame: months to years]
|
|
Secondary ID(s)
|
|
H-D-2007-0050
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|